MoleSense
AI-powered platform for early detection and monitoring of skin conditions, particularly melanoma.
About
Technology stack
detected 2026-05-25No comments yet. Be the first to share your take.
What does MoleSense do?
MoleSense is developing an AI-driven platform designed to assist individuals and healthcare professionals in the early detection and ongoing monitoring of skin conditions, with a primary focus on melanoma. The technology aims to provide accessible and accurate analysis of skin lesions through user-friendly interfaces.
How much funding has MoleSense raised?
MoleSense has raised a total of $2M in funding. The most recent round on record is Pre-Seed.
Where is MoleSense headquartered?
MoleSense is headquartered in Tel Aviv, Israel.
When was MoleSense founded?
MoleSense was founded in 2021.
What industry does MoleSense operate in?
MoleSense operates in HealthTech, MedTech, AI-Driven Drug Discovery, Computer Vision, Digital Twin Healthcare, Consumer App.
What is MoleSense's current status?
MoleSense's current operating status is: Inactive.